Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Crotalinae venom is a complex mixture of bioactive proteins and peptides produced by pit vipers, a subfamily of venomous snakes that includes rattlesnakes, copperheads, and cottonmouths (StatPearls, 2023). The venom serves both to immobilize prey and initiate digestion, containing a diverse array of toxins such as snake venom metalloproteinases (SVMPs), phospholipases A2 (PLA2s), and serine proteases (Journal of Venomous Animals and Toxins, 2016). These components act synergistically to cause local tissue destruction, systemic coagulopathy, and cardiovascular instability in human victims (NIH, 2021). In a therapeutic context, Crotalinae venom is the primary target for antivenom treatments, which utilize purified antibody fragments to bind and neutralize the toxic components (FDA, 2018). These antivenoms, such as CroFab and Anavip, are essential for managing complications like coagulopathy and preventing permanent tissue damage (Unified Treatment Algorithm, 2011). Understanding the specific composition of Crotalinae venom is crucial for the development of effective treatments for snakebite envenomation and managing its clinical sequelae (WHO, 2017).
The mechanism of action involves the administration of venom-specific antibody fragments (Fab or F(ab')2) that bind to and neutralize the toxic proteins within the venom, preventing their interaction with host tissues and facilitating their clearance (FDA, 2018; StatPearls, 2023).
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Crotalinae venom.